TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹7,947 Cr | ₹8,138 Cr | ₹8,121 Cr | ₹6,423 Cr | ₹7,065 Cr |
What is the latest Net Block ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹7,947 Cr |
| Mar2024 | ₹8,138 Cr |
| Mar2023 | ₹8,121 Cr |
| Mar2022 | ₹6,423 Cr |
| Mar2021 | ₹7,065 Cr |
How is Net Block of TORRENT PHARMACEUTICALS Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,947 Cr | -2.35 | |
| Mar2024 | ₹8,138 Cr | 0.21 | |
| Mar2023 | ₹8,121 Cr | 26.45 | |
| Mar2022 | ₹6,423 Cr | -9.09 | |
| Mar2021 | ₹7,065 Cr | - | |
Compare Net Block of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹147,916.3 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
| MANKIND PHARMA | ₹92,672.7 Cr | 9.3% | 7.3% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.6% |
9.4% |
44.1% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses